|
1
|
World Health Organization, HIV/AIDS JUNPo
and UNICEF: Global HIV/AIDS response: Epidemic update and health
sector progress towards universal access. Progress Report 2011. WHO
Press. (Geneva). 2011.
|
|
2
|
Ambrosioni J, Calmy A and Hirschel B: HIV
treatment for prevention. J Int AIDS Soc. 14:282011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hao L, Sakurai A, Watanabe T, Sorensen E,
Nidom CA, Newton MA, Ahlquist P and Kawaoka Y: Drosophila RNAi
screen identifies host genes important for influenza virus
replication. Nature. 454:890–893. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kelly EJ, Hadac EM, Greiner S and Russell
SJ: Engineering microRNA responsiveness to decrease virus
pathogenicity. Nat Med. 14:1278–1283. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Pu C, Wang L, Miao X, Zhang Y, Jiang C,
Liu W, Sun W and Gao Q: Optimized tandem amLRNA mediates stronger
inhibitory effects on hepatitis B virus infection. J Gastrointestin
Liver Dis. 20:271–278. 2011.PubMed/NCBI
|
|
6
|
Ter Brake O, Legrand N, Von Eije KJ,
Centlivre M, Spits H, Weijer K, Blom B and Berkhout B: Evaluation
of safety and efficacy of RNAi against HIV-1 in the human immune
system (Rag-2(−/-)gammac(−/-)) mouse model. Gene Ther. 16:148–153.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Christensen HS, Daher A, Soye KJ, Frankel
LB, Alexander MR, Lainé S, Bannwarth S, Ong CL, Chung SW, Campbell
SM, et al: Small interfering RNAs against the TAR RNA binding
protein, TRBP, a Dicer cofactor, inhibit human immunodeficiency
virus type 1 long terminal repeat expression and viral production.
J Virol. 81:5121–5131. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lee NS, Dohjima T, Bauer G, Li H, Li MJ,
Ehsani A, Salvaterra P and Rossi J: Expression of small interfering
RNAs targeted against HIV-1 rev transcripts in human cells. Nat
Biotechnol. 20:500–505. 2002.PubMed/NCBI
|
|
9
|
Zhou J, Neff CP, Liu X, Zhang J, Li H,
Smith DD, Swiderski P, Aboellail T, Huang Y, Du Q, et al: Systemic
administration of combinatorial dsiRNAs via nanoparticles
efficiently suppresses HIV-1 infection in humanized mice. Mol Ther.
19:2228–2238. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Song E, Lee SK, Dykxhoorn DM, Novina C,
Zhang D, Crawford K, Cerny J, Sharp PA, Lieberman J, Manjunath N
and Shankar P: Sustained small interfering RNA-mediated human
immunodeficiency virus type 1 inhibition in primary macrophages. J
Virol. 77:7174–7181. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ter Brake O, Liu YP, Centlivre M, von Eije
KJ, Berkhout B and 't Hooft K: Lentiviral vector design for
multiple shRNA expression and durable HIV-1 inhibition. Mol Ther.
16:557–564. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Aagaard LA, Zhang J, von Eije KJ, Li H,
Saetrom P, Amarzguioui M and Rossi JJ: Engineering and optimization
of the miR-106b cluster for ectopic expression of multiplexed
anti-HIV RNAs. Gene Ther. 15:1536–1549. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu YP, Haasnoot J, ter Brake O, Berkhout
B and Konstantinova P: Inhibition of HIV-1 by multiple siRNAs
expressed from a single microRNA polycistron. Nucleic Acids Res.
36:2811–2824. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Grimm D, Streetz KL, Jopling CL, Storm TA,
Pandey K, Davis CR, Marion P, Salazar F and Kay MA: Fatality in
mice due to oversaturation of cellular microRNA/short hairpin RNA
pathways. Nature. 441:537–541. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jackson AL, Bartz SR, Schelter J,
Kobayashi SV, Burchard J, Mao M, Li B, Cavet G and Linsley PS:
Expression profiling reveals off-target gene regulation by RNAi.
Nat Biotechnol. 21:635–637. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Herrera-Carrillo E and Berkhout B: The
impact of HIV-1 genetic diversity on the efficacy of a
combinatorial RNAi-based gene therapy. Gene Ther. 22:485–495. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Scarborough RJ, Adams KL, Daher A and
Gatignol A: Effective inhibition of HIV-1 production by short
hairpin RNAs and small interfering RNAs targeting a highly
conserved Site in HIV-1 Gag RNA is optimized by evaluating
alternative length formats. Antimicrob Agents Chemother.
59:5297–5305. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Nejati A, Shahmahmoodi S, Shoja Z and
Marashi SM: Efficient inhibition of HIV replication by targeting
3UTR transcripts using new modified miR-30a. 4th World Congress on
Virology (San Antonio, TX, USA). 2014.
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCt method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Richman DD, Margolis DM, Delaney M, Greene
WC, Hazuda D and Pomerantz RJ: The challenge of finding a cure for
HIV infection. Science. 323:1304–1307. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Blankson JN, Persaud D and Siliciano RF:
The challenge of viral reservoirs in HIV-1 infection. Annu Rev Med.
53:557–593. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chung J, Zhang J, Li H, Ouellet DL,
DiGiusto DL and Rossi JJ: Endogenous MCM7 microRNA cluster as a
novel platform to multiplex small interfering and nucleolar RNAs
for combinational HIV-1 gene therapy. Hum Gene Ther. 23:1200–1208.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhou J, Neff CP, Swiderski P, Li H, Smith
DD, Aboellail T, Remling-Mulder L, Akkina R and Rossi JJ:
Functional in vivo delivery of multiplexed anti-HIV-1 siRNAs via a
chemically synthesized aptamer with a sticky bridge. Mol Ther.
21:192–200. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Coburn GA and Cullen BR: Potent and
specific inhibition of human immunodeficiency virus type 1
replication by RNA interference. J Virol. 76:9225–9231. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Novina CD, Murray MF, Dykxhoorn DM,
Beresford PJ, Riess J, Lee SK, Collman RG, Lieberman J, Shankar P
and Sharp PA: SiRNA-directed inhibition of HIV-1 infection. Nat
Med. 8:681–686. 2002.PubMed/NCBI
|
|
26
|
Saayman S, Barichievy S, Capovilla A,
Morris KV, Arbuthnot P and Weinberg MS: The efficacy of generating
three independent anti-HIV-1 siRNAs from a single U6 RNA Pol
III-expressed long hairpin RNA. PLoS One. 3:e26022008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
ter Brake O, Konstantinova P, Ceylan M and
Berkhout B: Silencing of HIV-1 with RNA interference: A multiple
shRNA approach. Mol Ther. 14:883–892. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Vickers TA, Lima WF, Nichols JG and Crooke
ST: Reduced levels of Ago2 expression result in increased siRNA
competition in mammalian cells. Nucleic Acids Res. 35:6598–6610.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lo HL, Chang T, Yam P, Marcovecchio PM, Li
S, Zaia JA and Yee JK: Inhibition of HIV-1 replication with
designed miRNAs expressed from RNA polymerase II promoters. Gene
Ther. 14:1503–1512. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
McManus MT, Petersen CP, Haines BB, Chen J
and Sharp PA: Gene silencing using micro-RNA designed hairpins.
RNA. 8:842–850. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zeng Y, Wagner EJ and Cullen BR: Both
natural and designed micro RNAs can inhibit the expression of
cognate mRNAs when expressed in human cells. Mol Cell. 9:1327–1333.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Das AT, Brummelkamp TR, Westerhout EM,
Vink M, Madiredjo M, Bernards R and Berkhout B: Human
immunodeficiency virus type 1 escapes from RNA
interference-mediated inhibition. J Virol. 78:2601–2605. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
von Eije KJ, ter Brake O and Berkhout B:
Human immunodeficiency virus type 1 escape is restricted when
conserved genome sequences are targeted by RNA interference. J
Virol. 82:2895–2903. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Birmingham A, Anderson EM, Reynolds A,
Ilsley-Tyree D, Leake D, Fedorov Y, Baskerville S, Maksimova E,
Robinson K, Karpilow J, et al: 3′-UTR seed matches, but not overall
identity, are associated with RNAi off-targets. Nat Methods.
3:199–204. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
35
|
Fedorov Y, Anderson EM, Birmingham A,
Reynolds A, Karpilow J, Robinson K, Leake D, Marshall WS and
Khvorova A: Off-target effects by siRNA can induce toxic phenotype.
RNA. 12:1188–1196. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Jackson AL, Burchard J, Schelter J, Chau
BN, Cleary M, Lim L and Linsley PS: Widespread siRNA ‘off-target’
transcript silencing mediated by seed region sequence
complementarity. RNA. 12:1179–1187. 2006. View Article : Google Scholar : PubMed/NCBI
|
